Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
HSD17B6 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody
Supplier: Novus Biologicals NBP131672
Description
HSD17B6 Polyclonal specifically detects HSD17B6 in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin.Specifications
HSD17B6 | |
Polyclonal | |
Unconjugated | |
0.1M Tris (pH 7.0), 0.1M Glycine and 10% Glycerol with 0.01% Thimerosal | |
HSD17B6 | |
Recombinant protein encompassing a sequence within the center region of human HSD17B6. The exact sequence is proprietary. | |
Affinity Purified | |
RUO | |
8630 | |
Human | |
IgG |
Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin) | |
0.71mg/mL | |
Western Blot 1:500-1:3000, Immunohistochemistry 1:100-1:1000, Immunohistochemistry-Paraffin 1:100-1:1000 | |
17-beta-HSD 6, 17-beta-HSD6, 17-beta-hydroxysteroid dehydrogenase type 6, 3(alpha->beta)-hydroxysteroid epimerase, 3-alpha->beta-HSE, EC 1.1.1, EC 1.1.1.105, EC 1.1.1.62, EC 1.1.1.63, HSE3-hydroxysteroid epimerase, hydroxysteroid (17-beta) dehydrogenase 6, hydroxysteroid (17-beta) dehydrogenase 6 homolog (mouse), NAD+ -dependent 3 alpha-hydroxysteroid dehydrogenase 3-hydroxysteroid epimerase, Oxidative 3-alpha hydroxysteroid dehydrogenase, oxidative 3-alpha-hydroxysteroid-dehydrogenase, oxidoreductase, retinol dehydrogenase, RODH3(alpha->beta)-hydroxysteroid epimerasel, SDR9C6, short chain dehydrogenase/reductase family 9C, member 6,3-alpha->beta-hydroxysteroid epimerase | |
Rabbit | |
36 kDa | |
0.1 mL | |
Primary | |
Tested in human. Predicted cross-reactivity based on sequence identity: Monkey (93%). Not yet tested in any other species. | |
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction